MTT assay
Cell proliferation was determined by MTT assay. Approximately 1×10 4 cells were seeded in 96-well microculture plates and incubated overnight. In the second day, different treatments were carried out and incubated for 0 to 4 days depended on the specific experiment. After incubation, chemical MTT 20 μl (5 mg/ml) was added to each well to the final concentration of 50 μg/ml, and the cells were further incubated for 4 h at 37 °C. At the end of the incubation, remove supernatant carefully without disturb the cells in the bottom and added 200 μl DMSO into each well. Shake the whole plate for 15 min. The microtiter plate was spectrophotometrically read at a wavelength of 570 nm, with a reference wavelength of 630 in a multi-well plate reader (Bio-Rad, Hercules, CA). Cell proliferation rate (%) = (Absorbance of treated cell/ Absorbance of untreated cell) ×100%.
Firefly luciferase reporter constructs and luciferase assays
Two different ZBP-89 (-2060-60 and -1201-60 relative to the transcription start site of NM_021964) and Bak (-2100-33 and -1198-33 relative to the transcription start site of NM_001188.3) promoter fragments were amplified from genomic DNA of human HCC cells by polymerase chain reaction (PCR). The PCR reaction was carried out at 94°C for 3 min, followed by 35 cycles at 95°C for 30 sec, 52-56°C for 45 sec and 72°C for 1 min. The PCR fragments of four promoter were inserted into luciferase reporter vector pGL3-Basic (Promega, Madison, WI, USA) digested by SacI/XhoI (Takara Biotechnology Co., Ltd., Dalian, China). All constructs were confirmed by SacI/XhoI digestion and DNA sequencing was confirmed by sequencing (ABI PRISMTM, Applied Biosystems, Foster City, CA). HCC cells (HepG2, Hep3B, and Bel-7404) were seeded into 24-well plates (1x10 5 cells/well). After 48 h, the cells were co-transfected with promoter plasmid (Bak or ZBP-89 or PDCD4 or pGL3-Basic), pcDNA3.1 or pcDNA3.1-HIF-2α, pRL-TK Renilla Luciferase Reporter (Promega), pshRNA-HIF-2α or a negative control with aid of Lipofectamine 2000 (Invitrogen) according to the manufacturers' instructions. At 24 h after the transfection, the cells were washed twice with phosphate-buffered saline (PBS) and then were harvested and lysed in RIPA. The luciferase assays were performed with the Luciferase Assay System (Promega). The following primers were used for ZBP-89 and Bak promoter construction.
ZBP-89 pro_SacI-F1: GGT GAGCTCTGAATATG CGGTTAACTGTG Z BP-89 pro_SacI-F2: GAAGAGCTCAGGCATC ACGATTTACTAAG Z BP-89 pro_XhoI-R: GTTCTCGAGCCACTGCC GGCCCGGTGCA Bak1 pro_SacI-F1: CGAGAGCTCAGTTTCGCTCT TGTTGACC Bak1 pro_SacI-F2: CAAGAGCTCGGAACTCCT GCACCTGGC Bak1 pro_XhoI-R: GAACTCGAGGAAGTTGCT CTGTGGC.
Xenograft animal model
Female nude mice (4 weeks old) were purchased from the Laboratory Animal Services Centre of the Chinese University of Hong Kong (Hong Kong SAR, China). The animals were kept in a temperature controlled room (23 ± 2°C) with a 12 h light: 12 h dark cycle. To generate HCC xenografts, Lv-HIF-2α or Lv-controlinfected HepG2 cells were harvested from mid-log phase cultures using trypsin-EDTA, pelleted and resuspended in phosphate buffer saline (PBS) to a final cell count of 5×10 6 /ml. A volume of 150 µl of the cell suspension was injected subcutaneously in the left flank of each mouse. Tumor weight was calculated weekly using the equation: (length × (width) 2 )/2. Four weeks after the cell implantation, the tumors were excised intact and weighted. Tumor tissues were subjected to H&E staining and immunohistochemical staining. The tissue lysate was analyzed by real-time PCR and Western blot to detect the expression of HIF-2α, ZBP-89, and PDCD4. 
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